Parts of the World Seeing New COVID-19 Variant
Medically reviewed by Drugs.com.
By Stephanie Brown HealthDay Reporter
WEDNESDAY, May 28, 2025 -- Health officials at the World Health Organization are warning of a rise in cases from a new COVID-19 variant.
The new variant, NB.1.8.1, has been spotted in the Mediterranean, Southeast Asia, and Western Pacific regions. Airport screenings in the United States have identified the new variant in travelers arriving from affected regions. These travelers were heading to destinations in California, Washington state, Virginia, and New York, the Associated Press reported.
As of mid-May, this variant has been identified in nearly 11 percent of sequenced samples reported worldwide. The WHO has designated this variant as a "variant under monitoring," and currently assesses the public health risk as low at the global level, with the expectation that current vaccines will remain effective against it.
Meanwhile, the U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced earlier this week that his agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women. Currently, the U.S. Food and Drug Administration recommends the COVID-19 booster only for adults 65 years and older and those with certain health conditions that put them at increased risk for severe complications.
"WHO continues to monitor emerging SARS-CoV-2 variants and undertakes risk evaluation for designated variants of interest and variants under monitoring with the support of the Technical Advisory Group of Virus Evolution," the WHO stated in an outbreak update. "Evaluation of the currently predominant variant under monitoring, LP.8.1, and the most recently designated variant under monitoring, NB.1.8.1, suggests no increased public health risk posed by these variants compared to other circulating variants."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-29 12:00
Read more

- In New SELECT Trial Analysis, Early Reduction in Cardiovascular Events Was Observed with Wegovy®, Before Clinically Meaningful Changes in Body Weight
- FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia
- No Causal Link Seen Between Stimulant Prescription, Psychotic Experience
- Multicancer Early Detection Screening Improves Patient Outcomes
- Ocugen Announces Rare Pediatric Disease Designation Granted for OCU410ST - Modifier Gene Therapy for the Treatment of Stargardt Disease
- Hypertensive Disorders of Pregnancy Adversely Affect Preemie Neurodevelopment
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions